Clinical Trial Update: No Treatment Versus Oral Ibuprofen Treatment for Patent Ductus Arteriosus in Preterm Infants [Phase 2]

View source ↗

Summary

Phase 2 trial comparing no treatment to oral ibuprofen for patent ductus arteriosus in preterm infants; study completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia

Drugs mentioned

• Ibuprofen (IBUPROFEN)

Snippet

Sponsor: Samsung Medical Center | Conditions: Bronchopulmonary Dysplasia (BPD) | Phase 2 | Status: COMPLETED